Soros Fund Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-230,893
| Closed | -$28.1M | – | 235 |
|
|
2024
Q4 | $28.1M | Buy |
230,893
+24,310
| +12% | +$2.96M | 0.42% | 54 |
|
|
2024
Q3 | $25.8M | Buy |
+206,583
| New | +$25.8M | 0.37% | 55 |
|
|
2024
Q2 | – | Sell |
-3,956
| Closed | -$512K | – | 207 |
|
|
2024
Q1 | $512K | Buy |
+3,956
| New | +$512K | 0.01% | 162 |
|
|
2022
Q4 | – | Sell |
-101,500
| Closed | -$11.2M | – | 208 |
|
|
2022
Q3 | $11.2M | Buy |
+101,500
| New | +$11.2M | 0.19% | 69 |
|
|
2014
Q4 | – | Sell |
-325,000
| Closed | -$6.86M | – | 253 |
|
|
2014
Q3 | $6.86M | Sell |
325,000
-355,000
| -52% | -$7.49M | 0.05% | 164 |
|
|
2014
Q2 | $20.3M | Buy |
680,000
+655,000
| +2,620% | +$19.5M | 0.15% | 105 |
|
|
2014
Q1 | $601K | Sell |
25,000
-208,000
| -89% | -$5M | 0.01% | 246 |
|
|
2013
Q4 | $4.75M | Sell |
233,000
-432,274
| -65% | -$8.81M | 0.04% | 160 |
|
|
2013
Q3 | $31.4M | Buy |
665,274
+239,585
| +56% | +$11.3M | 0.34% | 61 |
|
|
2013
Q2 | $16.2M | Buy |
+425,689
| New | +$16.2M | 0.18% | 77 |
|